Impaired contrast sensitivity at low spatial frequency in cannabis users with early onset

Autor: Lalanne, Laurence, Ferrand-Devouge, Eglantine, Kirchherr, Sebastien, Rauch, Lucie, Koning, Estelle, Speeg, Claude, Laprevote, Vincent, Giersch, Anne

Publikováno v: In European Neuropsychopharmacology December 2017 27(12):1289-1297

Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol

Autor: Auriacombe, Marc, Roux, Perrine, Briand Madrid, Laélia, Kirchherr, Sébastien, Kervran, Charlotte, Chauvin, Carole, Gutowski, Marie, Denis, Cécile, Carrieri, Maria Patrizia, Lalanne, Laurence, Jauffret-Roustide, Marie

Publikováno v: BMJ Open
BMJ Open, 2019, 9 (2), pp.e023683. ⟨10.1136/bmjopen-2018-023683⟩
BMJ Open, BMJ Publishing Group, 2019, 9 (2), pp.e023683. ⟨10.1136/bmjopen-2018-023683⟩

International audience; Introduction The high prevalence of hepatitis C and the persistence of HIV and hepatitis C virus (HCV) risk practices in people who inject drugs (PWID) in France underlines the need for innovative prevention interventions. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b7efd37caf3ac2a45c486f6bf0fd736d
https://hal.science/hal-02479765/document

Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol.

Autor: Auriacombe M; University of Bordeaux, Bordeaux, Aquitaine, France.; Addiction Team, SANPSY, CNRS USR 3413, Bordeaux, France.; Department of Psychiatry, University of Pennsylvania Center for Studies of Addiction, Philadelphia, Pennsylvania, USA.; Pôle Addictologie, CH Charles Perrens and CHU de Bordeaux, Bordeaux, France., Roux P; Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France.; ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France., Briand Madrid L; Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France.; ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France., Kirchherr S; Department of Psychiatry and Addictology, INSERM 1114, University Hospital of Strasbourg, Strasbourg, France., Kervran C; University of Bordeaux, Bordeaux, Aquitaine, France.; Addiction Team, SANPSY, CNRS USR 3413, Bordeaux, France., Chauvin C; CERMES3 (INSERM U988/UMR CNRS 8211/EHESS/Paris Descartes University), Paris, France., Gutowski M; Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France.; ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France., Denis C; Addiction Team, SANPSY, CNRS USR 3413, Bordeaux, France.; Department of Psychiatry, University of Pennsylvania Center for Studies of Addiction, Philadelphia, Pennsylvania, USA., Carrieri MP; Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France.; ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France., Lalanne L; INSERM U1114, Strasbourg, Alsace, France.; Department of Psychiatry and Addictology, Hopitaux universitaires de Strasbourg, Strasbourg, France., Jauffret-Roustide M; CERMES3 (INSERM U988/UMR CNRS 8211/EHESS/Paris Descartes University), Paris, France.

Publikováno v: BMJ open [BMJ Open] 2019 Feb 21; Vol. 9 (2), pp. e023683. Date of Electronic Publication: 2019 Feb 21.